Syros Pharmaceuticals Inc. (SYRS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Adage Capital Management

Phill Gross And Robert Atchinson

2,071,914 $16,140,210 +188% 0.03%
2.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

1,786,427 $13,916,266 +103% 2.16%
3.
Avidity Partners Management

David Witzke And Michael Gregory

1,673,538 $13,036,861 +6% 0.47%
4. 1,471,771 $11,465,096 0.02%
5. 828,485 $6,453,898 0.21%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.42 904,977 Director 1,786,427 2023-12-21 Filing
$6.37 14,000 Director 24,932 2022-09-30 Filing
$5.72 2,932 Director 10,932 2022-09-29 Filing
$8.86 10,000 Director 10,000 2020-05-13 Filing
$4.97 10,121 Officer 35,000 2019-11-12 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.95 6,287 0 2023-12-12 Filing
$3.95 6,287 6,287 2023-12-06 Filing
$3.95 7,348 Officer 0 2023-07-31 Filing
$3.50 689 Officer 6,661 2023-07-17 Filing
$3.47 2,208 Officer 0 2022-01-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 2,749,808 $21,421,004 2.05%
2. 1,293,848 $10,079,076 0.76%
3. 764,812 $5,957,886 0%
4. 251,270 $1,957,393 1.58%
5. 246,944 $1,923,694 0%
News See All